1991
DOI: 10.1002/eji.1830211220
|View full text |Cite
|
Sign up to set email alerts
|

Monoclonal antibodies raised against engineered soluble mouse T cell receptors and specific for Vα8‐, Vβ2‐ or Vβ10‐bearing T cells

Abstract: We have characterized a panel of monoclonal antibodies (mAb) produced by immunizing rats with two distinct soluble mouse alpha/beta T cell receptor (TcR). Fifty mAb were found to react with the corresponding surface-bound TcR. Such observations suggest that the soluble TcR molecules used as immunogen are folded in a conformation similar to the native structure. Furthermore, the binding to T cells of four antibodies was found to correlate with the expression of the V alpha 8, V beta 2 or V beta 10 gene segments… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
38
0

Year Published

1993
1993
2002
2002

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 72 publications
(38 citation statements)
references
References 43 publications
0
38
0
Order By: Relevance
“…NOD/Lt mice were bred at the animal facility at Dana-Farber Cancer Institute (Boston, MA). The following mAbs were used: anti-I-A k' r. s. ~ g7 (10-2.16, [21]); anti-I-A a (MK-D6, [22]), anti-Ib4 (11b11, [23]); anti-IL-2 receptor (PC 61 5.3; TIB-222; American Type Culture CoLlection, RockviLle, MD); anti-V~2 (B20.6, [24]); anti-V/~8 (F23.1, [25]); and anti-VB14 (14-2, [26]). The peptides used, Pl (yTYTVHAAHAYTYt; small letters denote D amino acids) and P2 (KMKMVH-AAHAKMKM) (27), were synthesized at Dana-Farber Cancer Institute core facility.…”
Section: Methodsmentioning
confidence: 99%
“…NOD/Lt mice were bred at the animal facility at Dana-Farber Cancer Institute (Boston, MA). The following mAbs were used: anti-I-A k' r. s. ~ g7 (10-2.16, [21]); anti-I-A a (MK-D6, [22]), anti-Ib4 (11b11, [23]); anti-IL-2 receptor (PC 61 5.3; TIB-222; American Type Culture CoLlection, RockviLle, MD); anti-V~2 (B20.6, [24]); anti-V/~8 (F23.1, [25]); and anti-VB14 (14-2, [26]). The peptides used, Pl (yTYTVHAAHAYTYt; small letters denote D amino acids) and P2 (KMKMVH-AAHAKMKM) (27), were synthesized at Dana-Farber Cancer Institute core facility.…”
Section: Methodsmentioning
confidence: 99%
“…B20.6 is a rat mAb (IgG2a) specific for the product of the mouse Vp2 gene segment [6]. B21.14 is a rat mAb (IgG1) specific for the product of some of the mouse Va8 gene segments [22]. B21.5 (rat IgG) and B21-7D4.…”
Section: Antibodiesmentioning
confidence: 99%
“…B21.5 (rat IgG) and B21-7D4. (rat IgG2a) are two mAb specific for the product of the mouse VplO gene segment [22].…”
Section: Antibodiesmentioning
confidence: 99%
“…The anti-Va2.1 specific mAb B20.1 [28], the anti-VP8.l mAb F23.1 [29] and the anti-CD3e mAb 145-2~11 [30] were purified from culture supernatants using protein G (Pharmacia, Uppsala, Sweden). The anti-t chain mAb G3 [31] was a generous gift from N. van Oers (University of California, San Francisco, CA).…”
Section: Antibodiesmentioning
confidence: 99%